B, and C. Rimler et al. (11) confirmed the serovar A of Page and described the Modesto strain as a new agglutinin serovar C-type isolate, the original type C isolate of Page having been lost. Sawata et al. (13) used an agglutination test to serotype isolates of H. paragallinaruml in Japan and found two serovars, designated 1 and 2. In a further study (14) , they found that serovars 1 and 2 were equivalent to serovars A and C, respectively, of Page (8) and Rimler et al. (11) .
The agglutinin schemes of Page (8) and Rimler et al. (11) were used at our laboratory in two studies on Australian and South African isolates of H. paragallinaruin. Both studies indicated the presence of serovars A and C, with serovar C predominating. No serovar B isolates were found (3, 16) . A significant number of strains were either nonserotypeable or autoagglutinating, resulting in only 85 and 62Yc, respectively, of strains being serotyped in each study. Hyaluronidase treatment, used to remove any masking hyaluronic acid capsule (11, 12) , failed to significantly improve the results (3, 16) .
Kume et al. (6) found that untreated antigens prepared from serovar 1 isolates agglutinated fresh chicken erythrocytes (RBC) and induced hemagglutination inhibition (HI) antibodies, while a similar antigen from serovar 2 isolates lacked these properties. However. Sawata et al. (15) were able to produce an antigen from serovar 2 isolates that * Corresponding author. agglutinated RBC which had been fixed previously with glutaraldehyde (GA) by means of treatment with potassium thiocyanate (KSCN) and sonication. Following this, Kume et ai. (5) proposed a new serotyping system for H. paragaillinarani based on hemagglutinins prepared by treatment with KSCN and sonication and using GA-fixed RBC. In examining 17 isolates with this scheme, Kume et al. (5) recognized three serogroups, which corresponded to the three agglutinin serovars of Page (8) and Rimler et al. (11) . These three hemagglutinin serogroups were subdivided into a total of seven serovars by cross-absorbing sera (5) .
The present study was undertaken to determine the occurrence of hemagglutinin serovars of H. paragallinaruin in Australia and to compare the results with those obtained by agglutinin serotyping in this and in previous studies. Of the Australian isolates of H. paragallinariutn, 65 were classified serologically by the hemagglutinin scheme of Kume et al. (5) and 18 were classified by the agglutinin schemes of Page (8) and Rimier et al. (11) . Thirty isolates of H. paragallinarumn from four other countries were available for testing and were included to provide some information on the geographic occurrence of the hemagglutinin serovars.
MATERIALS AND METHODS
Reference bacteria. (3, 16 ). An additional 36 isolates, comprising 18 from Australia and 18 from other countries, were serotyped as previously described (16) . and any antigens which were initially nonserotypeable were subjected to hyaluronidase treatment (3).
Antigens for hemagglutinins and antisera production. Cultures were grown overnight at 37°C on TM/SN in an atmosphere containing 5% CO.,. The growth was suspended in phosphate-buffered saline (PBS) (pH 7.2) to an optical density of 1.6 at 650 nm on a Gilford 2600 spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio).
Antisera for hemagglutinin scheme. Antisera to reference bacteria were prepared in rabbits by the technique described by Kume et 
RESULTS
With the agglutinin serotyping scheme, 24 isolates were serotyped; 10 were nonserotypeable and 2 were autoagglutinating. Fourteen isolates were assigned to serovar A, two were assigned to serovar B, and eight were assigned to serovar C. Of the 65 Australian isolates, 49 were serotyped as serovar HA-5 by the hemagglutinin serotyping system. One isolate could not be serotyped, as the antigen failed to agglutinate GA-fixed RBC. The remaining 15 Australian isolates could not be serotyped as any of the existing 7 hemagglutinin serovars. Although they reacted with unabsorbed antisera to isolates 221, 2403, and E-3C (serovars HA-1, HA-2, and HA-3, respectively) at 1:160 or greater, hemagglutinins prepared from these isolates were not inhibited by any of the absorbed antisera. Two of these isolates, HP14 and HP62.
were selected, and an antiserum to each was prepared in rabbits. HP14 and HP62 antisera had reciprocal HI titers of 10,240 and 2,560, respectively, when tested against either HP14 or HP62 hemagglutinins. When tested against serovars HA-1, HA-2, and HA-3 hemagglutinins, HP14 had HI titers ranging from 320 to 1,280 and HP62 titers ranging from 320 to 640. No HI activity against serovars HA-4 to HA-7 hemagglutinins was detected. Following absorption with E-3C (serovar HA-3) hemagglutinin (Table 2) , the HI activity against serovars HA-1 to HA-3 hemagglutinins was removed. HP14 then had a reciprocal HI titer of 320, and HP62 had a titer of 80 when tested against either HP14 or HP62 hemagglutinins. These absorbed antisera inhibited agglutination of GA-fixed RBC by hemagglutinins prepared from all of the 15 Australian isolates that could not be serotyped with the seven reference-absorbed antisera. A new hemagglutinin serovar, designated HA-8, was identified, with HP14 as the serovar reference isolate.
The results of hemagg!utinin serotyping of the 95 field isolates of H. paragallinaruin are presented in Table 3 , and they are compared with agglutinin serotyping results from both this and the two previous studies in Table 4 .
DISCUSSION
Of the 95 isolates tested in this study, 47 from Australia and 13 from South Africa were included in two previous agglutinin-serotyping studies in which 85 and 62%Hf, respectively, of isolates were serotyped (3, 16) . Similar results were obtained in this study, since 24 of the 36 isolates (67%W) could be serotyped by the agglutinin system following hyaluronidase treatment of nonserotypeable antigens. Thus, by the agglutinin system, only 60 of the 95 isolates (631%-) were serotypeable, with 29 being nonserotypeable and 6 being autoagglutinating. This result may be due to the presence of some substance other than a hyaluronic acid capsule, which masks the serospecific antigens detected in the agglutinin test (3) .
Only one of the seven hemagglutinin serovars designated by Kume et al. (5) was found among the Australian isolates. (Table 3) .
The use of an extracted antigen in a HI test avoids the problems of autoagglutination and nonreaction due to masked surface antigens, which occur in agglutination tests. Sawata et al. (15) suggested that the treatment of serovar 2 (serovar C of Page) isolates with KSCN and sonication might act to remove a surface substance surrounding the organism which inhibits hemagglutinating activity, but the mechanism is still unclear. The absence of hemagglutinating activity in the antigen prepared from one Australian isolate would suggest either a failure to remove such a surface inhibitor or the absence of a hemagglutinin in this isolate. The serovarspecific hemagglutinins HA-LI and HA-L2 of Sawata (serovars 1 and 2, respectively) have been shown to correlate with protection against challenge by the homologous isolate (15) . Further examination of the nonhemagglutinating isolate is warranted to determine both whether it is pathogenic and whether it could be used to prepare an effective vaccine.
Experimental, inactivated, aluminum hydroxide gel, infectious coryza vaccines have been produced in this laboratory and shown to be protective (2, 9) only against the agglutinin serovars present in the vaccine (4). Similar findings have been reported by others (6, 7, 11) . Because of the predominance of agglutinin serovar C, a monovalent serovar C vaccine is now commercially available in Australia. How 
